HSP90 inhibitors (Aegera Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameHSP90 inhibitors (Aegera Therapeutics)
Drug Alias Nameheat shock protein-90 inhibitors (Aegera Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 inhibitors
TargetsHeat shock protein HSP90
Therapy Area/IndicationsInflammationAutoimmune DiseasesCentral Nervous System Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAegera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAegera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesCentral Nervous System Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A